Supriya Lifescience (NSE:SUPRIYA) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 29, 2026)


NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
81 GF Score
Price ₹928.15
GF Value ₹805.85
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Supriya Lifescience Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Supriya Lifescience's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:SUPRIYA vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Supriya Lifescience's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Supriya Lifescience Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's Margin of Safety % (DCF Earnings Based) falls into.


NSE:SUPRIYA
81GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued. The current stock price of ₹928.15 is trading 15.2% above its estimated GF Value™ of ₹805.85. GuruFocus considers Supriya Lifescience to be Modestly Overvalued.

Key valuation signals for NSE:SUPRIYA:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹805.85 vs. price of ₹928.15 (15.2% above fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
81GF Score

Get the complete analysis for NSE:SUPRIYA

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹928.15
Price
₹805.85
GF Value